Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme (original) (raw)
Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570)
J. Fichelle
European Journal of Pharmacology, 1988
View PDFchevron_right
Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril)
Emanuel Bravo
Hypertension, 1984
View PDFchevron_right
Angiotensin Converting Enzyme in the Rat Heart: Studies of Its Inhibition in Vitro and Ex Vivo
Frederick Mendelsohn
Clinical and Experimental Pharmacology and Physiology, 1989
View PDFchevron_right
Safety and tolerance of single oral doses of trandolapril (RU 44.570), a new angiotensin converting enzyme inhibitor
A GO GO
European Journal of Clinical Pharmacology, 1989
View PDFchevron_right
Trandolapril: A newer angiotensin-converting enzyme inhibitor
David Guay
Clinical Therapeutics, 2003
View PDFchevron_right
In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme
Frederick Mendelsohn
American Journal of Cardiology, 1982
View PDFchevron_right
Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography
Frederick Mendelsohn
Hypertension, 1988
View PDFchevron_right
Haemodynamic effects of enalapril, a new converting enzyme inhibitor, in hypertensive patients
Adalberto Urbina
European Journal of Clinical Pharmacology, 1985
View PDFchevron_right
Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: Therapeutic implications
Thomas Unger
The American Journal of Cardiology, 1987
View PDFchevron_right
Acute and Chronic Effects of Angiotensin-Converting Enzyme Inhibitors on Tissue Angiotensin-Converting Enzyme
Frederick Mendelsohn
Clinical and Experimental Pharmacology and Physiology, 1992
View PDFchevron_right
Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II
Olaf Drummer
Biochemical Pharmacology, 1990
View PDFchevron_right
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system
J. Biollaz
British Journal of Clinical Pharmacology, 1982
View PDFchevron_right
Initial blood pressure response to enalapril in hospitalized patients (studies of left ventricular dysfunction [SOLVD])☆
Marston Youngblood
The American Journal of Cardiology, 1991
View PDFchevron_right
Determinants of angiotensin II generation during converting enzyme inhibition
Yves Christen
Hypertension, 1990
View PDFchevron_right
Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension
maurizio castellano
American Journal of Cardiology, 1982
View PDFchevron_right
Effects of converting enzyme inhibitors: Ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart
Thomas Unger
European Journal of Pharmacology, 1985
View PDFchevron_right
Acute and Chronic Effects of Perindopril on Tissue Angiotensin Converting Enzyme Activity
Frederick Mendelsohn
American Journal of Hypertension, 1991
View PDFchevron_right
Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats
Frederick Mendelsohn
British Journal of Pharmacology, 1990
View PDFchevron_right
Effect of Time and Dose on Angiotensin Converting Enzyme during Captopril Treatment in the Rat
T. Forslund
Acta Pharmacologica et Toxicologica, 1983
View PDFchevron_right
Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system
John W Keddie
The American Journal of Cardiology, 1982
View PDFchevron_right
Effects of trandolapril on the sympathetic tone and reactivity in systemic hypertension
Michel Bouvier
The American Journal of Cardiology, 1994
View PDFchevron_right
A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients
Abul Basher
Journal of the American College of Cardiology, 2001
View PDFchevron_right
Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans
F. Perret
American Heart Journal, 1989
View PDFchevron_right
Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluations
Lorenzo DiCarlo
Journal of the American College of Cardiology, 1983
View PDFchevron_right
Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat
Pablo Castro
2009
View PDFchevron_right